Dr Aidan Cole is a Consultant Clinical Oncologist specialising in all aspects of treatment relating to prostate cancer from early disease through to advanced metastatic disease.
He is an academic researcher in Queen’s University Belfast dedicated to improving treatments for men with prostate cancer through research and clinical trials. He has trained primarily in Belfast and also has a keen interest in Medical Education, he is currently the Module Lead for the Cancer Studies Training for our Medical Undergraduates in Belfast.
Dr Aidan Cole has in addition, completed a year-long Advanced Radiotherapy Fellowship in the Peter MacCallum Cancer Centre in Melbourne. He is a Clinical Advisor to the Steering Committee of the Northern Ireland Cancer Registry.
Kingsbridge Hospital/352 Consulting Rooms
Northern Ireland Cancer Centre
Current NHS Posts
Consultant Clinical Oncologist, NI Cancer Centre
NI Lead for Stereotactic Radiotherapy in Oligometastatic Disease
Married with three sons, Dr Aidan Cole is (or was) a keen sportsman in multiple sports. He is a multi-code underage sports coach and enjoys running.
MB BCH BAO
Queen’s University of Belfast 2003
Diploma in Oncology
Institute of Cancer Research 2008
Doctor of Philosophy (PhD)
Queen’s University Belfast 2014
Post Graduate Certificate of Education (Clinical Education-PGCE)
Queen’s University 2016
Advanced Radiotherapy Fellowship, Peter MacCallum Cancer Centre Melbourne 2016-2017
Fellow of the Royal College of Radiologists of London FRCR 2015
Member of the Royal College of Physicians of Edinburgh (MRCP) 2007
CT-based Radiomics for Risk Stratification in Prostate Cancer. Osman S, Leijenaar RT, Cole AJ, Lyons CA, Hounsell AR, Prise KM, O’Sullivan JM, Lambin P, McGarry CK, Jain S. Published June 2019 International Journal of Radiation, Physics and Biology. https://doi.org/10.1016/j.ijrobp.2019.06.2504
Systematic Endobronchial Ultrasound-Transbronchial Needle Aspiration improves radiotherapy planning in non-small cell lung cancer. Cole AJ, Turgeon GA, Hardcastle N, Kron T, Ball D, Jennings B, Irving L, Steinfort D, Siva S. ERJ Open Research 2019 5: 00004-2019; DOI: 10.1183/23120541.00004-2019
A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypofractionated radiotherapy alone for the treatment of prostate cancer. Crowther K, Cole AJ, Shiels, P, Jain S, Shepherd P, Mitchell D. Technical Innovations and Patient Support in Radiation Oncology 2019 (9) 18-25
What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC) EORTC, PERCIST, Peter Mac or Deauville criteria? Turgeon, Guy-Anne; Iravani, Amir; Akhurst, Tim; Beaulieu, Alexis; Callahan, Jason W; Bressel, Mathias; Cole, Aidan J; Everitt, Sarah; Siva, Shankar; Hicks, Rodney J; Ball, David L; Mac Manus, Michael P.In: The Journal of Nuclear Medicine, 20.07.2018, p. 1-42.
Blyth, B, Cole AJ, MacManus M, Martin, OA. Radiation therapy-induced metastasis: radiobiology and clinical implications. 2017. Clinial and Experimental Metastasis. 2017 Nov 20. doi: 10.1007/s10585-017-9867-5.
Alderdice M, Dunne PD, Cole AJ, O’Reilly PG, McArt DG, Bingham V, Marc-Aurel Fuchs, McQuaid S, Loughrey MB, Murray GI, Samuel LM, Lawler M, Wilson RH, Salto-Tellez, Coyle VM. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival. 2017 Modern Pathology 30, 1287-1298
Butterworth KT, McMahon SJ, McKee JC, Patel G, Ghita M, Cole AJ, McGarry CK, O’Sullivan JM, Hounsell AR, Prise KM. Time and Cell Type Dependency of Survival Responses in Co-Cultured Tumor and Fibroblast Cells after Exposure to Modulated Radiation Fields. Radiation Research. 2015 May 14. 183(6), 656-664. DOI: 10.1667/RR13992.1
O'Connell B, Irvine DM, Cole AJ, Hanna GG, McGarry CK. Optimizing geometric accuracy of four dimensional CT scans acquired using the wall and couch mounted Varian Real-Time Position Management camera systems. Br J Radiol. 2014 Dec 3:20140624.
Cole AJ, Hanna GG. Sterotactic radiotherapy for early stage lung cancer. 2015 Ulster Medical Journal. 84(1) 69-70
Cole AJ, O'Hare JM, McMahon SJ, McGarry CK, Butterworth KT, McAleese J, Jain S, Hounsell AR, Prise KM, Hanna GG, O'Sullivan JM. Investigating the Potential Impact of Four-dimensional Computed Tomography (4DCT) on Toxicity, Outcomes and Dose Escalation for Radical Lung Cancer Radiotherapy. Clin Oncol (R Coll Radiol). 2014 Mar;26(3):142-50. doi: 10.1016/j.clon.2013.11.024.
Cole AJ, Hanna GG, Jain S, O'Sullivan JM. Motion management for radical radiotherapy in non-small cell lung cancer. Clin Oncol (R Coll Radiol). 2014 Feb;26(2):67-80. doi: 10.1016/j.clon.2013.11.001.
Hyland WB, McMahon SJ, Butterworth KT, Cole AJ, King RB, Redmond KM, Prise KM, Hounsell AR, McGarry CK. Investigation into the radiobiological consequences of pre-treatment verification imaging with megavoltage X-rays in radiotherapy. Br J Radiol 2014, Apr 87(1036).
Cole AJ, McGarry CK, Butterworth KT, McMahon SM, Hounsell AR, Prise KM, O’Sullivan JM. Investigating the influence of respiratory motion on the radiation induced bystander effect in modulated radiotherapy. 2013. Phys Med Biol 7;58(23) 8311-22
King RB, Hyland WB, Cole AJ, Butterworth KT, McMahon SJ, Redmond KM, Trainer C, Prise KM, McGarry CK, Hounsell AR. An in vitro study of the radiobiological effects of flattening filter free radiotherapy treatments. 2013. Phys Med Biol 2013, 7 (58) N83-94.
Cole AJ, McGarry CK, Butterworth KT, Prise KM, O’Sullivan JM, Hounsell AR. Development of a novel experimental model to investigate radiobiological implications of respiratory motion in advanced radiotherapy. 2012 Phys Med Biol, 57(22) N411-20
Cole AJ, Pridee NR, McAleer JJ. Chemotherapy causes cancer! A case report of therapy related acute myeloid leukaemia in early stage breast cancer. 2013. Ulster Med Journal 82(2) 97-99